Genetic and Structural Variations in Czech Patients With Congenital Myopathies

Investor logo

Warning

This publication doesn't include Institute of Computer Science. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Authors

ZÍDKOVÁ Jana LAUEROVA Barbora MENSOVA Livie KRAMÁŘOVÁ Tereza KOPČILOVÁ Johana RÉBLOVÁ Kamila SOUKUP VODIČKOVÁ Magdaléna HUJŇÁKOVÁ Martina HABERLOVA Jana ROHLENOVA Marie MAZANEC Radim SOUKALOVA Jana GAILLYOVÁ Renata VYHNALKOVA Emilie BALASCAKOVA Miroslava DANHOFER Pavlína JUŘÍKOVÁ Lenka GRECMALOVA Dagmar GREGOROVA Andrea PLEVOVA Pavlina LANGOVA Martina HONZIK Tomas MAGNER Martin KLINCOVÁ Martina SOLAROVA Pavla SENKERIKOVA Maria FAJKUSOVÁ Lenka

Year of publication 2025
Type Article in Periodical
Magazine / Source Clinical Genetics
MU Faculty or unit

Faculty of Medicine

Citation
web https://onlinelibrary.wiley.com/doi/10.1111/cge.14782
Doi https://doi.org/10.1111/cge.14782
Keywords breakpoint analysis; congenital myopathy; deletion; structural variants
Description Congenital myopathies (CMs) are a heterogeneous group of genetic muscle disorders characterized by hypotonia and muscle weakness, with pathogenic variants identified in at least 41 genes and inheritance patterns including autosomal dominant (AD), recessive (AR), and X-linked (XL). We present 79 unrelated patients with genetically confirmed CM using next-generation sequencing (NGS). A total of 113 mutant alleles carrying 97 different variants with a presumed pathogenic effect were identified. According to the HGMD database, 54 of these variants have been reported exclusively in the Czech CM population to date. All but five variants were small-scale. Large gene deletions were identified in the MTM1, NEB, and RYR1 genes. Sequencing of breakpoint junctions in the identified NEB and RYR1 deletions provided insights into the upstream mechanisms leading to genomic instability and resulting in structural variations. We present the family with dominant inheritance of the NEB deletion of exons 19-78. We assume that our family represents another reported case of a dominant mutation in the NEB gene. Our results contribute to further knowledge in the field of neuromuscular diseases and mutational mechanisms.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info